Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

A2 ME3031 MSK > W10 - Multi-System AuImm; Juvenile Idiopathic Arth.; Rheumatology Hx Taking > Flashcards

W10 - Multi-System AuImm; Juvenile Idiopathic Arth.; Rheumatology Hx Taking Flashcards

1
Q

Understand the interaction between genetic and environmental factors in the pathogenesis of connective tissue disease

A

in SLE: Genetics and Env: UV, drugs, infections

Systemic Sclerosis: Silica, solvents, viral infections; Genetics

*hormonal influence too d/t prevalence in females = oestrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Illustrate the role of the various components of the immune system in the causation of tissue damage in connective tissue disease

A
  • ANA AuAb common immunology
  • often elevated in patients with systemic lupus erythematosus (“lupus”), Sjogren’s syndrome, scleroderma,

Vs pANCA
(ANCA) is a blood test commonly elevated in patients with diseases such granulomatosis with polyangiitis, microscopic polyangiitis, and EGPA/Churg-Strauss syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Demonstrate a knowledge of the various immunological tests used in the diagnosis of connective tissue disease

A 
Antinuclear antibody (ANA), includes anticentromere
Double stranded DNA antibodies (IgG); Crithida Antibodies (if appropriate)

ENA antibodies includes: Ro (SS-A 52, SSA-60), La (SS-B), Sm, Sm/RNP, RNP (RNP A, RNP 68), Ribo P,
Chromatin and Jo-1, and Scl-70

Immunoglobulins (IgG, IgA, IgM)

Complement C3, Complement C4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the prevalence, presentation, diagnosis and clinical manifestations of Systemic Lupus Erythematosus (SLE)

A

immune response against endogenous nuclear Ag > imm complex formation > complement activation > tissue injury
* fever, wt. loss, malaise, fatigue

  • butterfly rash (malar rash)
  • Discoid rash (raised, scarring, permanent marks, alopecia)
  • Photosens
  • Oral Ulcers
  • Arthritis
  • Lupus Nephritis
  • Pleuritic chest pain
  • ANA AuAb
  • Anti -ds DNA = highly spec. for SLE; nephritis
  • Anti -Smith
  • Anti-Ro
  • Antiphospholipid Ab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the prevalence, presentation, diagnosis and clinical manifestations of scleroderma/ systemic sclerosis,

A

diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs (especially the esophagus, lower gastrointestinal tract, lungs, heart, and kidneys).

* Limited cutaneous: 
anti-centromere ab; pulm. HT; GI
* Diffuse cutaneous:
anti Scl70 Ab, Pulm Fibrosis, renal crisis, SIBO
* F>M; 30-40yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the prevalence, presentation, diagnosis and clinical manifestations and compl. of Sjogren’s syndrome

A

parts of the body that produce fluids, like tears and spit (saliva).

*F»M; 40-50yrs

*dry eyes and mouth
* Parotid enlargement
+ systemic upset

  • Anti Ro, Anti La Ab
  • Lip biopsy
  • Salivary gland biopsy

compl: lymphoma, neuropathy, cutaneous vasculitis, intersitital lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the prevalence, presentation, diagnosis and clinical manifestations of polymyositis

A

autoimmune disease involving chronic inflammation that leads to the weakening of muscles over time, particularly those in the neck, shoulders, hips and back
* pelvic girdle

  • F>M, 50-60yo
  • ⇧risk of malignancy
  • symmetrical; proximal muscl. weakness
  • EMG, MRI, muscle biopsy
  • cutaenous papules and rash
  • skin involvement = DERMATOMYOSITOSIS
  • ⇧CK
  • anti Jo1 Ab = interstitial lung disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the prevalence, presentation, diagnosis and clinical manifestations of dermatomyositis

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the prevalence, presentation, diagnosis and clinical manifestations of mixed connective tissue disease

A

RAYNAUDS

SOFT TISSUE SWELLING

MYOSITIS

ARTHRALGIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

immunological abnormalities in connective tissue disease

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dx; Mgmt; Compl. of giant cell arteritis

A

(3/5)

  • ≤50yr
  • new headache
  • temporal artery tenderness
  • ESR ≤50
  • abn temporal biopsy
  • USS doppler; CT angio.; MR angio; FDF PET

> Prednisolone, tapered
PPI
Bone protection

compl: irreversible visual loss, ao aneurysms; arterial stenosis; limb ischaemia; stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vasculitides

A

Large, medium and small vessel inflamm = ischaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ANCA associated vasculitis

A
  1. granulomatosis with polyangiitis (Wegener’s)
  2. Microscopic polyangiitis
  3. Eosiniphilic granulomatosis with polyangiitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Wegener’s Polyangiitis (GPA)

A

Necrotising granulomatous inflamm = resp tract

  • hearing loss, sinusitis, hemoptysis
  • necrotising glomerulonephritis
  • cANCA, antiPR3 Ab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Microscopic polyangiitis (MPA)

A

necrotising vasculitis, few or nil immune deposits = small vessels

  • nil granulomatous inflamm
  • RENAL and PULMONARY INVOLVEMENT
  • pANCA, antiMPO Ab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Churg Strauss - Eosiniphilic granulomatosis with polyangiitis

A

eosinophi rich and necrotising granulomatous inflamm
* resp. tract
* late asthma, nasal polyps, eosinophilia
+neuro involvement
+ GI, cardiac = poor prognosis

  • antiMPOAb +
17
Q

45 year old female patient
3-day history of breathlessness and right sided chest pain worse with deep inspiration
CXR confirms right pleural effusion
Treatment with antibiotics makes no difference
FBC showed persistently low WCC of 3.0 then 3.2 and low platelets of 100
Over the last year she has been experiencing intermittent pain and swelling in her joints and recurrent facial rash after sun exposure

Likely diagnosis?

A

SLE

women
cytopenia
arthritis
pleuritic chest pain
photosens
18
Q

45 year old female patient
3-day history of breathlessness and right sided chest pain worse with deep inspiration
CXR confirms right pleural effusion
Treatment with antibiotics makes no difference
FBC showed persistently low WCC of 3.0 then 3.2 and low platelets of 100
Over the last year she has been experiencing intermittent pain and swelling in her joints and recurrent facial rash after sun exposure

Bedside assessment to prioritise?

BP
Fundoscopy
Auscultation for carotid bruits
Urine dipstck

A

Urine dipstick = ID any endstage renal impairment

19
Q

45 year old female patient
3-day history of breathlessness and right sided chest pain worse with deep inspiration
CXR confirms right pleural effusion
Treatment with antibiotics makes no difference
FBC showed persistently low WCC of 3.0 then 3.2 and low platelets of 100
Over the last year she has been experiencing intermittent pain and swelling in her joints and recurrent facial rash after sun exposure

Which immunological test support clinical suspicion?

+ anti dsDNA Ab
reduced complement
+ anti smith Ab
+ antinuclear Ab

A

All

20
Q

The definition, aetiology, epidemiology of Juvenile Idiopathic Arthritis (JIA)

A

Group of systemic inflammatory disorders

  • <16yo
  • > 6w duration
  • Joint swelling or painful/limited joint motion, tenderness, warmth
  • Different to adult RA, with strong subset specific genetic markers influencing auto-immunity
21
Q

Types of JIA

A 
PAUCIARTICULAR (commonest)
4 or less joints
Type 1: 1-3yo peak, F>M
Type 2: post 8-9yo, M> F
Type 3: any age, F>M 
*can progress to polyarticular

POLYARTICULAR (2nd most common)
5 or more
RF -ve, any age
F>M

SYSTEMIC ONSET - least common
most serious short and LOT morbidity and mortality
throughout childhood

22
Q

Clinical manifestations of JIA - Pauciarticular

A

Type 1 Pauciarticular

  • limp rather than pain
  • Lower limb
  • Chronic uveitis or asymptomatic
  • ANA

Type 2 Pauciarticular

  • LL limp: knee, anke
  • progression to ankylosing spondylitis or spondyloarth.

Type 3 Pauciarticular
* asymmetric UL and LL arthritis
* Dactylitis
+FHx of psoriasis thus nail pitting

23
Q

Management and treatment of JIA including long-term rehabilitation

A

(1)
> NSAIDs
> steroid injection

(2)
> Mtrx
> Anti-TNF Rx
> IL-1 R antagonist (anakinra) = refractory systemic arth.
> IL-6 antagonist (Tocilizumab) = refractory systemic disease

(+)
> Local steroids: oligo-articular JIA
> systemic steroids for systemic JIA; serious complications, bridging between DMARDs + risk of osteoporosis, infections
> Rehab
>Sx: synovectomy; reconstructive/joint replacement

24
Q

Natural progression and complications of JIA

A

Pauciarticular can progress to polyarticular
with iris involvement etc.

?add more

25
Q

Clinical manifestations of JIA - Polyarticular

A

Polyarticular RF-ve

  • Systemic manifestation
  • hepato-splenomeg.
  • Mild anemia
  • growth abn.
  • symmetric large and small joints
Polyarticular RF+ve
*late childhood, teens; F>M
* systemic, anemia, nodules
* Early XR erosions
\+Vasculitis
\+ AR
26
Q

Clinical manifestations of JIA - Systemic

A

Extra-articular features which start early and disappear

*Pyrexia for at least 2w: late afternoon or evening
* RASH on trunk and thighs (+ve Koebners)
* Generalised lymphadenopathy
* Arthritis: within onset of fever
+ hepatosplenomegaly; abdo pain (+/- transaminase)

A2 ME3031 MSK (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions